Mother Term ID
1071
SDG Number
09
Image
Image
Industry, Innovation and Infrastructure

HKUST-Nurtured Healthtech Startups PanopticAI and SmartCare Partner with Gleneagles Hospital Hong Kong to Pioneer AI-Driven Patient Care Solutions

Two healthtech innovators nurtured by The Hong Kong University of Science and Technology (HKUST) - PanopticAI Limited (PanopticAI) and SmartCare Technology Co Limited (SmartCare), have entered a landmark collaboration with Gleneagles Hospital Hong Kong (Gleneagles). Witnessed by Prof. Nancy IP, President of HKUST; Dr. Prem Kumar NAIR, Group Chief Executive Officer of IHH Healthcare; and Dr.

HKUST-Nurtured Healthtech Startups PanopticAI and SmartCare - Preview

Two healthtech innovators nurtured by The Hong Kong University of Science and Technology (HKUST) - PanopticAI Limited (PanopticAI) and SmartCare Technology Co Limited (SmartCare), have entered a landmark collaboration with Gleneagles Hospital Hong Kong (Gleneagles). Witnessed by Prof. Nancy IP, President of HKUST; Dr. Prem Kumar NAIR, Group Chief Executive Officer of IHH Healthcare; and Dr.

HKUST Showcases Leadership in Med-Tech and AI at Asia Summit on Global Health

The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today.  As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for hundreds of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.  

HKUST Showcases Leadership in Med-Tech and AI at Asia Summit on Global Health - Preview

The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today.  As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for a thousand of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.  

HKUST Discovers Novel Elastic Alloy Achieving 20x Temperature Change and 90% Carnot Efficiency in Solid-State Heat Pumping

Researchers at the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have developed a novel elastic alloy called Ti₇₈Nb₂₂, which achieves remarkable efficiency for solid-state heat pumping and exhibits a reversible temperature change (ΔT) ability that is 20 times greater than that of conventional metals when stretched or compressed, offering a promising green alternative to traditional vapor-compression heating and cooling technologies.

HKUST Discovers Novel Elastic Alloy Achieving 20x Temperature Change and 90% Carnot Efficiency in Solid-State Heat Pumping - Preview

Researchers at the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have developed a novel elastic alloy called Ti₇₈Nb₂₂, which achieves remarkable efficiency for solid-state heat pumping and exhibits a reversible temperature change (ΔT) ability that is 20 times greater than that of conventional metals when stretched or compressed, offering a promising green alternative to traditional vapor-compression heating and cooling technologies.

HKUST Partners with Two Leading Shandong-Listed Pharma Companies

香港科技大學(科大)近日與山東兩大醫藥上市公司:綠葉製藥集團(綠葉製藥)與博安生物技術股份有限公司(博安生物)簽署合作協議,共同推動生物醫藥領域的前沿協作、成果轉化及人才培育,以支持科大發展醫療科技及申辦「香港生命健康研發院」等策略舉措。

深化前沿醫藥研究及人才培育合作

綠葉製藥是專注於創新藥物研發的領先中國醫藥企業,近年於中國內地、歐美、日本等主要醫藥市場成功上市13款新藥,在中樞神經系統(CNS)治療領域居領先地位。其子公司博安生物則是一家全面綜合性生物製藥公司,特別聚焦研發腫瘤、自身免疫、眼科和代謝疾病新藥及治療方法。根據協議內容,科大將與兩所企業就臨床前及臨床研究、前沿科學領域探索、人才培訓及交流和科研成果産業化等範疇展開深度協作。

其中,科大與博安生物將特別聚焦開發新型抗癌藥物和癌症新療法;與綠葉製藥則會集中研究神經科學與中樞神經系統疾病的新療法,以及先進藥物遞釋系統。此外,兩家企業亦將支持科大培育醫藥創新領域人才,為學生提供研究和實踐的產業基地,並提供相關科研技術落地應用平台。 

HKUST Partners with Two Leading Shandong-Listed Pharma Giants - Preview

香港科技大學(科大)近日與山東兩大醫藥上市公司﹕綠葉製藥集團(綠葉製藥)與博安生物技術股份有限公司(博安生物)簽署合作協議,共同推動生物醫藥領域的前沿協作、成果轉化及人才培育,以支持科大發展醫療科技及籌設「香港生命健康研發院」等策略舉措。

深化前沿醫藥研究及人才培育合作

綠葉製藥是專注於創新藥物研發的領先中國醫藥企業,近年於中國內地、歐美、日本等主要醫藥市場成功上市13款新藥,在中樞神經系統(CNS)治療領域居領先地位。其子公司博安生物則是一家全面綜合性生物製藥公司,特別聚焦研發腫瘤、自身免疫、眼科和代謝疾病新藥及治療方法。根據協議內容,科大將與兩所企業就臨床前及臨床研究、前沿科學領域探索、人才培訓及交流和科研成果産業化等範疇展開深度協作。

其中,科大與博安生物將特別聚焦開發新型抗癌藥物和癌症新療法;與綠葉製藥則會集中研究神經科學與中樞神經系統疾病的新療法,以及先進藥物遞釋系統。此外,兩家企業亦將支持科大培育醫藥創新領域人才,為學生提供研究和實踐的產業基地,並提供相關科研技術落地應用平台。 

Pioneering Climate Resilience and Sustainability: HKUST Launches Landmark UNESCO-Backed Initiative

The global transdisciplinary "research-to-operation" (R2O) initiative, “Seamless Prediction and Services for Sustainable Natural and Built Environments” (SEPRESS), led by The Hong Kong University of Science and Technology (HKUST), has been endorsed by the United Nations Educational, Scientific and Cultural Organization (UNESCO) as part of its International Decade of Sciences for Sustainable Development (IDSSD).

Pioneering Climate Resilience and Sustainability: HKUST Launches Landmark UNESCO-Backed Initiative - Preview

The global transdisciplinary "research-to-operation" (R2O) initiative, “Seamless Prediction and Services for Sustainable Natural and Built Environments” (SEPRESS), led by The Hong Kong University of Science and Technology (HKUST), has been endorsed by the United Nations Educational, Scientific and Cultural Organization (UNESCO) as part of its International Decade of Sciences for Sustainable Development (IDSSD).